| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 04/01/2008 | 23:35 | PR Newswire (US) | QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 03/01/2008 | 20:58 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 31/12/2007 | 15:11 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 31/12/2007 | 14:00 | Business Wire | Pfizer Inc Announces Completion of the Tender Offer Relating to Outstanding Shares of Coley Pharmaceutical Group, Inc. | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 21/12/2007 | 22:13 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Beneficial Ownership (SC 13D) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 18/12/2007 | 14:00 | Business Wire | Pfizer Inc Clears Antitrust Review for Acquisition of All Outstanding Shares of Coley Pharmaceutical Group, Inc. | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 14/12/2007 | 22:12 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 30/11/2007 | 14:59 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 30/11/2007 | 14:55 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Tender offer statement by Third Party (SC TO-T) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 28/11/2007 | 12:04 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 26/11/2007 | 19:29 | PR Newswire (US) | Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 20/11/2007 | 22:50 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Current report filing (8-K/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 19/11/2007 | 18:58 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Amended Statement of Ownership (SC 13G/A) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 16/11/2007 | 22:15 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Current report filing (8-K) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 16/11/2007 | 15:35 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 01/11/2007 | 21:05 | PR Newswire (US) | Coley Pharmaceutical Group Reports Third Quarter and Nine-month Financial Results | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 31/10/2007 | 19:24 | PR Newswire (US) | Coley Pharmaceutical Group to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 30/10/2007 | 14:00 | PR Newswire (US) | Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 29/10/2007 | 14:00 | PR Newswire (US) | Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythemat | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 26/10/2007 | 17:34 | PR Newswire (US) | Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 25/10/2007 | 14:30 | PR Newswire (US) | Coley Pharmaceutical Group to Report Third Quarter Results on November 1, 2007 | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 09/10/2007 | 14:11 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. - Securities Registration (section 12(b)) (8-A12B) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 08/10/2007 | 14:30 | PR Newswire (US) | Coley Pharmaceutical Group Adopts Shareholder Rights Plan | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 20/09/2007 | 21:18 | Edgar (US Regulatory) | Coley Pharmaceutical Group, Inc. (Other) (4) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 05/09/2007 | 14:30 | PR Newswire (US) | Coley Pharmaceutical Group to Present at Bear, Stearns & Co. 20th Annual Healthcare Conference | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 02/08/2007 | 22:05 | PR Newswire (US) | Coley Pharmaceutical Group Reports Second Quarter and Six-month Financial Results | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 31/07/2007 | 14:30 | PR Newswire (US) | Coley Pharmaceutical Group to Present at the Canaccord Adams 27th Annual Global Growth Conference | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 25/07/2007 | 14:30 | PR Newswire (US) | Coley Pharmaceutical Group to Report Second Quarter Results on August 2, 2007 | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 28/06/2007 | 23:02 | PR Newswire (US) | Coley Pharmaceutical Group Grants Dynavax License for Commercialization of HEPLISAV(TM) | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |
| 20/06/2007 | 20:57 | PR Newswire (US) | Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic Chemothe | NASDAQ:COLY | Coley Pharmaceutical Grp. (MM) |